{
    "2020-09-10": [
        [
            {
                "time": "",
                "original_text": "高瓴资本加速全球扫货，半年5次增持这家公司，能否迎来‘寒武纪时代’大爆发？",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "全球扫货",
                        "增持",
                        "寒武纪时代",
                        "大爆发"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "科技",
                        "投资"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "资本狂欢下的「拆分上市」热潮",
                "features": {
                    "keywords": [
                        "资本",
                        "拆分上市",
                        "热潮"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融",
                        "资本市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药（600196）：贝伐珠单抗类似药报产 生物药进入收获期",
                "features": {
                    "keywords": [
                        "复星医药",
                        "贝伐珠单抗",
                        "类似药",
                        "生物药",
                        "收获期"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}